Baxano

About Baxano

Baxano, Inc. was a medical device company established in 2005 in San Jose, California, which focused on developing minimally invasive surgical tools for treating degenerative conditions of the lumbar spine. The company's business model centered on designing, manufacturing, and marketing these specialized products to surgeons and hospitals. Its target market was the minimally invasive spine surgery sector, serving patients with conditions like lumbar spinal stenosis.

The company developed a portfolio of products designed to preserve healthy tissue while restoring spine function. A key product line was the iO-Flex® system, a set of flexible instruments that allowed surgeons to perform lumbar decompression with minimal disruption to a patient's anatomy. This system included the MicroBlade Shaver™ for removing bone and ligament, and the Neuro Check device to ensure nerve safety during procedures. Another significant product was the iO-Tome™, an instrument for precise bone removal, specifically around the facet joints, to create a clear channel for fusion procedures. Baxano also received FDA clearance for its Avance MIS pedicle screw system, which provided posterior fixation of the spine with minimal tissue trauma.

A major milestone for Baxano occurred in June 2013 when it was acquired by TranS1 Inc. for approximately $23.6 million. Following the acquisition, TranS1 changed its name to Baxano Surgical, Inc. and its stock began trading under the ticker BAXS. This merger combined TranS1's AxiaLIF® and VEO™ lumbar fusion products with Baxano's decompression systems, aiming to create a more comprehensive offering in the minimally invasive spine market. However, the company faced challenges, including a $6 million settlement in July 2013 over allegations of causing false claims to be submitted to Medicare by promoting incorrect billing codes. In November 2014, Baxano Surgical filed for Chapter 11 bankruptcy protection due to declining sales linked to a lack of product reimbursement. Subsequently, its assets were sold off; Amendia, Inc. acquired the iO-Flex and iO-Tome product lines in February 2015, and ChoiceSpine, LP acquired the VEO Lateral Access & Interbody Fusion System.